Your Guide to the Social Security Compassionate Allowances Program

For individuals facing a severe, life-threatening, or profoundly debilitating illness, the standard Social Security Disability application process can be a long and agonizing journey. The Social Security Administration (SSA) created the Compassionate Allowances (CAL) program to address this need, providing a fast-track process for claims involving the most serious disabilities. 

As stated in a recent press release, “The addition of new conditions aims to accelerate disability determinations for people with serious medical conditions, the agency said.”

What is the Compassionate Allowances Program and How Does it Work? 

The Compassionate Allowances (CAL) program is an initiative designed to provide swift access to disability benefits for individuals with medical conditions that are so severe they almost always meet the SSA’s strict definition of disability. The SSA uses a predictive model to automatically flag claims with a diagnosis that matches a condition on the official CAL list. 

Once identified, these claims are sent for an accelerated review. This allows a disability examiner to prioritize your case and often approve it based solely on the medical evidence confirming your diagnosis, without the need for a full, multi-stage evaluation. 

Key Data: The average processing time for a CAL claim is approximately 19 days, compared to the national average of over 200 days for a standard claim. Since the program’s inception, it has helped over 1.1 million people with severe disabilities get approved. 

How Do I Apply for Social Security Compassionate Allowance? 

This is one of the most common questions about the program, and the answer is crucial: you do not apply for a Compassionate Allowance separately. 

The application process is exactly the same as a standard SSDI or SSI application. The SSA’s computer system automatically scans your application and supporting medical records for keywords and diagnoses that are on the CAL list. 

For your claim to be correctly flagged, you must: 

1. File a standard SSDI or SSI application. 
2. Provide comprehensive medical records that clearly state your qualifying diagnosis. This is the most critical step, as the SSA’s system relies on this documentation. 

How Much is Compassionate Allowance? 

The Compassionate Allowance program does not affect the amount of benefits you receive. It only fast-tracks the decision-making process. The amount of your monthly benefit is the same as it would be if you were approved through a standard process. 

Your monthly benefit amount is determined by: 

• SSDI: Your work history and the total Social Security taxes you have paid over your working life. 

• SSI: Your financial need, including your income and resources. 

How Long does the Compassionate Allowance benefit last? 

A Compassionate Allowance is not a temporary benefit. Once approved, the benefits are indefinite as long as you continue to meet the SSA’s criteria for disability. Your case will be subject to a periodic review, just like any other disability case, to ensure your condition is still severe enough to prevent you from working. 

Why a CAL Diagnosis Doesn’t Guarantee Approval 

While having a CAL condition significantly increases your chances of a quick approval, it is not a 100% guarantee. Your claim can still be denied if: 

• You don’t meet non-medical criteria: For SSDI, you must have a qualifying work history and have paid enough into the system. For SSI, you must meet strict income and resource limits. 

• Incomplete Medical Records: The SSA requires comprehensive medical documentation to confirm your diagnosis. Incomplete or missing records can lead to delays or denials. 

Need help with your SSD claim? If you have a serious medical condition and believe it may be on the Compassionate Allowances list, or you’re looking for help applying or appealing, don’t wait. Contact us today for a free case evaluation. Our team can help you navigate the application process and ensure your claim is processed as quickly as possible.

Compassionate Allowances List of Conditions  

The SSA’s official list contains 300 medical conditions as of the August 2025 update. The SSA periodically adds new conditions to the list based on public feedback, medical expert advice, and research. 

Below is a list of conditions, in alphabetical order for easy reference.
For a complete and updated list, you should always consult the official SSA website. 

• 1p36 Deletion Syndrome
• Acute Leukemia
• Adrenal Cancer – with distant metastases or inoperable, unresectable or recurrent
• Adult Heart Transplant Wait List – Status Levels 1-4
• Adult Non-Hodgkin Lymphoma
• Adult Onset Huntington Disease
• Aicardi-Goutieres Syndrome
• Alexander Disease (ALX) – Neonatal and Infantile
• Allan-Herndon-Dudley Syndrome
• Alobar Holoprosencephaly
• Alpers Disease
• Alpha Mannosidosis – Type II and III
• ALS/Parkinsonism Dementia Complex
• Alstrom Syndrome
• Alveolar Soft Part Sarcoma 
• Amegakaryocytic Thrombocytopenia 
• Amyotrophic Lateral Sclerosis (ALS) 
• Anaplastic Adrenal Cancer – Adult with distant metastases or inoperable, unresectable or recurrent 
• Anaplastic Ependymoma 
• Angelman Syndrome 
• Angioimmunoblastic T-Cell Lymphoma 
• Angiosarcoma 
• Aortic Atresia 
• Aplastic Anemia 
• Astrocytoma – Grade III and IV 
• Ataxia Telangiectasia 
• Atypical Teratoid/Rhabdoid Tumor 
• Au-Kline Syndrome (New) 
• Bainbridge-Ropers Syndrome 
• Batten Disease 
• Beta Thalassemia Major 
• Bilateral Anophthalmia (New) 
• Bilateral Optic Atrophy- Infantile 
• Bilateral Retinoblastoma 
• Bladder Cancer – with distant metastases or inoperable or unresectable 
• Blastic Plasmacytoid Dendritic Cell Neoplasm 
• Breast Cancer – with distant metastases or inoperable or unresectable 
• CACH–Vanishing White Matter Disease-Infantile and Childhood Onset Forms 
• Calciphylaxis 
• Carey-Fineman-Ziter Syndrome (New) 
• Canavan Disease (CD) 
• Carcinoma of Unknown Primary Site 
• Cardiac Amyloidosis- AL Type 
• Caudal Regression Syndrome – Types III and IV 
• CDKL5 Deficiency Disorder 
• Cerebro Oculo Facio Skeletal (COFS) Syndrome 
• Cerebrotendinous Xanthomatosis 
• Charlevoix-Saguenay Spastic Ataxia 
• Child Heart Transplant Wait List – Status Levels 1A/1B 
• Child Lymphoblastic Lymphoma 
• Child Lymphoma 
• Child Neuroblastoma – with distant metastases or recurrent 
• Cholangiocarcinoma 
• Chondrosarcoma – with multimodal therapy 
• Choroid Plexus Carcinoma 
• Chronic Idiopathic Intestinal Pseudo Obstruction 
• Chronic Myelogenous Leukemia (CML) – Blast Phase 
• CIC-rearranged Sarcoma 
• Coffin-Lowry Syndrome 
• Congenital Lymphedema 
• Congenital Myotonic Dystrophy 
• Congenital Zika Syndrome 
• Cornelia de Lange Syndrome – Classic Form 
• Corticobasal Degeneration 
• Costello Syndrome 
• Creutzfeldt-Jakob Disease (CJD) – Adult 
• Cri du Chat Syndrome 
• Degos Disease – Systemic 
• DeSanctis Cacchione Syndrome 
• Desmoplastic Mesothelioma 
• Desmoplastic Small Round Cell Tumors 
• Dravet Syndrome 
• Duchenne Muscular Dystrophy- Adult 
• Early-Onset Alzheimer’s Disease 
• Edwards Syndrome (Trisomy 18) 
• Eisenmenger Syndrome 
• Endometrial Stromal Sarcoma 
• Endomyocardial Fibrosis 
• Ependymoblastoma (Child Brain Cancer) 
• Erdheim Chester Disease 
• Esophageal Cancer 
• Esthesioneuroblastoma 
• Ewing Sarcoma 
• Farber’s Disease (FD) – Infantile 
• Fatal Familial Insomnia 
• Fibrodysplasia Ossificans Progressiva 
• Fibrolamellar Cancer 
• Follicular Dendritic Cell Sarcoma – metastatic or recurrent 
• FOXG1 Syndrome 
• Friedreich’s Ataxia (FRDA) 
• Frontotemporal Dementia (FTD), Pick’s Disease -Type A – Adult 
• Fryns Syndrome 
• Fucosidosis – Type 1 
• Fukuyama Congenital Muscular Dystrophy 
• Fulminant Giant Cell Myocarditis 
• Galactosialidosis – Early and Late Infantile Types 
• Gallbladder Cancer 
• Gaucher Disease (GD) – Type 2 
• Gerstmann-Straussler-Scheinker Disease 
• Giant Axonal Neuropathy 
• Glioblastoma Multiforme (Brain Cancer) 
• Glioma – Grade III and IV 
• Glutaric Acidemia – Type II 
• GM1 Gangliosidosis – Infantile and Juvenile Forms 
• Harlequin Ichthyosis – Child (New) 
• Head and Neck Cancers – with distant metastasis or inoperable or unresectable Heart Transplant Graft Failure 
• Hematopoietic Stem Cell Transplantation (New) 
• Hemophagocytic Lymphohistiocytosis (HLH) – Familial Type 
• Hepatoblastoma 
• Hepatocellular Carcinoma 
• Hepatopulmonary Syndrome 
• Hepatorenal Syndrome 
• Histiocytic Malignancies 
• Histiocytosis Syndromes 
• Hoyeraal-Hreidarsson Syndrome 
• Hutchinson-Gilford Progeria Syndrome 
• Hydranencephaly 
• Hypocomplementemic Urticarial Vasculitis Syndrome 
• Hypophosphatasia Perinatal (Lethal) and Infantile Onset Types 
• Hypoplastic Left Heart Syndrome 
• I Cell Disease 
• Idiopathic Pulmonary Fibrosis 
• Infantile Free Sialic Acid Storage Disease 
• Infantile Neuroaxonal Dystrophy (INAD) 
• Infantile Neuronal Ceroid Lipofuscinoses 
• Inflammatory Breast Cancer (IBC) 
• Intracranial Hemangiopericytoma 
• Jervell and Lange-Nielsen Syndrome 
• Joubert Syndrome 
• Junctional Epidermolysis Bullosa – Lethal Type 
• Juvenile Onset Huntington Disease 
• Kidney Cancer – inoperable or unresectable 
• Kleefstra Syndrome 
• Krabbe Disease (KD) – Infantile 
• Kufs Disease – Type A and B 
• Large Intestine Cancer – with distant metastasis or inoperable, unresectable or recurrent 
• Late Infantile Neuronal Ceroid Lipofuscinoses 
• Leber Congenital Amaurosis 
• Leigh’s Disease 
• Leiomyosarcoma 
• Leptomeningeal Carcinomatosis 
• Lesch-Nyhan Syndrome (LNS) 
• Lewy Body Dementia 
• Liposarcoma – metastatic or recurrent 
• Lissencephaly 
• LMNA-related Congenital Muscular Dystrophy (New) 
• Lowe Syndrome 
• Lymphomatoid Granulomatosis – Grade III 
• Malignant Brain Stem Gliomas – Childhood 
• Malignant Ectomesenchymoma 
• Malignant Gastrointestinal Stromal Tumor 
• Malignant Germ Cell Tumor 
• Malignant Multiple Sclerosis 
• Malignant Renal Rhabdoid Tumor 
• Mantle Cell Lymphoma (MCL) 
• Maple Syrup Urine Disease 
• Marshall-Smith Syndrome 
• Mastocytosis – Type IV 
• MECP2 Duplication Syndrome 
• Medulloblastoma 
• Megacystis Microcolon Intestinal Hypoperistalsis Syndrome 
• Megalencephaly Capillary Malformation Syndrome 
• Menkes Disease – Classic or Infantile Onset Form 
• Merkel Cell Carcinoma – with metastases 
• Merosin Deficient Congenital Muscular Dystrophy 
• Metachromatic Leukodystrophy (MLD) – Late Infantile 
• Metastatic Endometrial Adenocarcinoma 
• Microvillus Inclusion Disease – Child 
• Mitral Valve Atresia 
• Mixed Dementias 
• Mowat-Wilson Syndrome 
• MPS I, formerly known as Hurler Syndrome 
• MPS II, formerly known as Hunter Syndrome 
• MPS III, formerly known as Sanfilippo Syndrome 
• Mucosal Malignant Melanoma 
• Multicentric Castleman Disease 
• Multiple System Atrophy 
• Myelodysplastic Syndrome with Excess Blasts 
• Myoclonic Epilepsy with Ragged Red Fibers Syndrome 
• Neonatal Adrenoleukodystrophy 
• Neonatal Marfan Syndrome 
• Nephrogenic Systemic Fibrosis 
• Neurodegeneration with Brain Iron Accumulation – Types 1 and 2 
• NFU-1 Mitochondrial Disease 
• Nicolaides-Baraister Syndrome 
• Niemann-Pick Disease (NPD) – Type A 
• Niemann-Pick Disease-Type C 
• Nonketotic Hyperglycinemia 
• Non-Small Cell Lung Cancer 
• NUT Carcinoma 
• Obliterative Bronchiolitis 
• Ohtahara Syndrome 
• Oligodendroglioma Brain Cancer- Grade III 
• Ornithine Transcarbamylase (OTC) Deficiency 
• Orthochromatic Leukodystrophy with Pigmented Glia 
• Osteogenesis Imperfecta (OI) – Type II 
• Osteosarcoma, formerly known as Bone Cancer – with distant metastases or inoperable or unresectable 
• Ovarian Cancer – with distant metastases or inoperable or unresectable 
• PACS1 Syndrome 
• Pallister-Killian Syndrome 
• Pancreatic Cancer 
• Paraneoplastic Cerebellar Degeneration 
• Paraneoplastic Pemphigus 
• Patau Syndrome (Trisomy 13) 
• Pearson Syndrome 
• Pelizaeus-Merzbacher Disease-Classic Form 
• Pelizaeus-Merzbacher Disease-Connatal Form 
• Pericardial Mesothelioma 
• Peripheral Nerve Cancer – metastatic or recurrent 
• Peritoneal Mesothelioma 
• Peritoneal Mucinous Carcinomatosis 
• Perry Syndrome 
• Pfeiffer Syndrome – Types II and III 
• Phelan-McDermid Syndrome 
• Pineoblastoma – Childhood 
• Pitt Hopkins Syndrome 
• Plasmablastic Lymphoma 
• Pleural Mesothelioma 
• Pompe Disease – Infantile 
• Pontocerebellar Hypoplasia 
• Posterior Cortical Atrophy 
• Primary Central Nervous System Lymphoma 
• Primary Effusion Lymphoma 
• Primary Omental Cancer 
• Primary Peritoneal Cancer 
• Primary Progressive Aphasia 
• Progressive Bulbar Palsy 
• Progressive Multifocal Leukoencephalopathy 
• Progressive Muscular Atrophy (New) 
• Progressive Supranuclear Palsy 
• Prostate Cancer – Hormone Refractory Disease – or with visceral metastases 
• Pulmonary Amyloidosis – AL Type (New) 
• Pulmonary Atresia 
• Pulmonary Kaposi Sarcoma 
• Rasmussen Encephalitis (New) 
• Refractory Hodgkin Lymphoma 
• Renal Amyloidosis – AL Type 
• Renal Medullary Carcinoma 
• Renpenning Syndrome 
• Retinopathy of Prematurity – Stage V, Bilateral 
• Rett (RTT) Syndrome 
• Revesz Syndrome 
• Rhabdomyosarcoma 
• Rhizomelic Chondrodysplasia Punctata 
• Richter Syndrome 
• Roberts Syndrome 
• Rubinstein-Taybi Syndrome 
• Salivary Cancers 
• Sandhoff Disease 
• Sarcomatoid Carcinoma of the Lung – Stages II – IV 
• Sarcomatoid Mesothelioma 
• Schindler Disease – Type 1 
• SCN8A Related Epilepsy with Encephalopathy 
• Seckel Syndrome 
• Secondary Adenocarcinoma of the Brain 
• Severe Combined Immunodeficiency – Childhood 
• Single Ventricle 
• Sinonasal Cancer 
• Sjogren-Larsson Syndrome 
• Skin Malignant Melanoma with Metastases 
• Small Cell Cancer Large Intestine 
• Small Cell Cancer of the Female Genital Tract 
• Small Cell Lung Cancer 
• Small Intestine Cancer – with distant metastases or inoperable, unresectable or recurrent 
• Smith Lemli Opitz Syndrome 
• Snijders Blok-Campeau Syndrome 
• Soft Tissue Sarcoma – with distant metastases or recurrent 
• Spinal Muscular Atrophy (SMA) – Types 0 and 1 
• Spinal Nerve Root Cancer-metastatic or recurrent 
• Spinocerebellar Ataxia 
• Stiff Person Syndrome 
• Stomach Cancer – with distant metastases or inoperable, unresectable or recurrent 
• Subacute Sclerosing Panencephalitis 
• Superficial Siderosis of the Central Nervous System 
• SYNGAP1-related NSID 
• Tabes Dorsalis 
• Tay Sachs Disease – Infantile Type 
• Taybi-Linder Syndrome 
• Tetrasomy 18p 
• Thanatophoric Dysplasia – Type 1 
• Thyroid Cancer 
• Thymic Carcinoma (New) 
• Transplant Coronary Artery Vasculopathy 
• Tricuspid Atresia 
• Trisomy 9 
• Turnpenny Fry Syndrome (New) 
• Ullrich Congenital Muscular Dystrophy 
• Ureter Cancer – with distant metastases or inoperable, unresectable or recurrent 
• Usher Syndrome – Type I 
• Ventricular Assist Device Recipient – Left, Right, or Biventricular 
• Walker Warburg Syndrome 
• WHO Grade III Meningiomas (New) 
• Wolf-Hirschhorn Syndrome 
• Wolman Disease 
• X-Linked Lymphoproliferative Disease 
• X-Linked Myotubular Myopathy 
• Xeroderma Pigmentosum 
• Zellweger Syndrome 
• Zhu-Tokita-Takenouchi-Kim Syndrome (New)

FAQs for “People Also Ask” / AI Search